grant

Personalized Prediction of Atopic Dermatitis Disease Course Across Diverse Settings

Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 19 Sept 2025Deadline 30 Jun 2028
NIHUS FederalResearch GrantFY20250-11 years old12-20 years old21+ years oldAD/HDADHDAddressAdolescenceAdultAdult HumanAgeAllergicAllergic DiseaseAllergyAnxietyAsthmaAtopic DermatitisAtopic EczemaAtopic NeurodermatitisAttention deficit hyperactivity disorderBiological Response Modifier TherapyBiological TherapyBirthBronchial AsthmaCardiacCardiometabolic DiseaseCardiometabolic DisorderChildChild YouthChildhoodChildren (0-21)ClinicalClinical EvaluationClinical TestingClinical TrialsCounselingDataDevelopmentDiabetes MellitusDiseaseDisorderDisseminated NeurodermatitisDrugsDrynessDyslipidemiasEarly treatmentEcuadorEczemaEczematous DermatitisEnrollmentEnvironmental FactorEnvironmental Risk FactorEuropeanEvaluation of Risk FactorsFailureFamilyFutureGeneticGenetic RiskGoalsGuidelinesHypertensionInflammatoryLifeLong-term Follow-upMeasuresMedicationMental DepressionMetabolicMetabolic DiseasesMetabolic DisorderModelingModificationNatural HistoryNatureObesityOnset of illnessOutcomeParentsParturitionPatientsPatternPerformancePharmaceutical PreparationsPopulation HeterogeneityPredicting RiskPredominantly Hyperactive-Impulsive Type Attention-Deficit DisorderPredominantly Hyperactive-Impulsive Type Hyperactivity DisorderProbabilityPrognosisRecommendationResearchRisk FactorsRisk ReductionSYS-TXSafetySample SizeSamplingSeriesSkinSkin CareStandardizationSystemic TherapyTestingThesaurismosisUgandaUncertaintyUnited KingdomVascular Hypertensive DiseaseVascular Hypertensive Disorderadiposityadolescence (12-20)adulthoodagesallergic dermatitisallergic eczemabiological therapeuticbiological treatmentbiologically based therapeuticsbiotherapeuticsbiotherapyclinical testco-morbidco-morbiditycohortcomorbiditycorpulencecostdata diversitydepressiondesigndesigningdevelopmentaldiabetesdisease onsetdisorder onsetdiverse datadiverse populationsdoubtdrug/agentearly childhoodearly onsetearly therapyeczematousenrollenvironmental riskforecasting riskheterogeneous populationhigh blood pressurehigh riskhyperpiesiahyperpiesishypertensive diseasehypertensive disorderimprovedindividualized predictionsinfancyinfantilekidslong-term followupmachine learning based methodmachine learning methodmachine learning methodologiesmetabolism disorderneuropsychiatricneuropsychiatric diseaseneuropsychiatric disorderneuropsychiatryparentparticipant enrollmentpatient enrollmentpatient stratificationpatient subclasspatient subclusterpatient subgroupspatient subpopulationspatient subsetspatient subtypespediatricpersonalized predictionspopulation diversitypredict riskpredict riskspredicted riskpredicted riskspredicting riskspredictive riskpredicts riskpreventpreventingprognosis modelprognosticprognostic modelprognostic performanceprognostic toolreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskresearch clinical testingrisk predictionrisk predictionsrisk-reducingstandardize measurestratified patienttoolyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Atopic dermatitis often presents in early childhood and is characterized by a heterogeneous disease course:

while some children improve by adolescence, many others continue to have persistent disease and develop

comorbid allergic, neuropsychiatric, and metabolic conditions. Prognostic information is needed for patient

counseling…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Personalized Prediction of Atopic Dermatitis Disease Course Across Diverse Settings — UNIVERSITY OF CALIFORNIA, SAN FRAN | Dev Procure